ClinicalTrials.gov Identifier: NCT02581189
This is a type IV phase trial.
This study seeks to provide evidence of the effectiveness and obtain patient reported outcome (PRO) data for the interferon-free ABBVIE REGIMEN ± RBV in participants with chronic hepatitis C (CHC) in a real life setting across clinical practice patient populations in Canada.
- Male and Female
- Ages 18 Years to 99 Years